Abstract:
수술 시 어둡고 출혈이 많은 조직을 박리할 때 수술 부위에서 발생하는 출혈을 흡입하고 조명을 비추어 조직 박리의 심도가 깊은 수술 부위의 시야를 확보할 수 있는 수술 기구가 개시된다. 본 발명의 수술 기구는 선단에 흡입구가 적어도 하나 형성되는 제 1 몸체부와, 제 1 몸체부와 교차되어 회전 가능하게 결합되는 제 2 몸체부와, 수술 중 환자의 출혈 부위에서 발생하는 혈액을 흡입구를 통해 흡입하기 위해 제 1 몸체부에 구비되는 흡입부와, 제 1 및 제 2 몸체부의 선단 사이를 조명하기 위해 제 2 몸체부에 구비되는 조명부를 포함할 수 있다. 조직 박리, 흡입, 광섬유, 조명, LED
Abstract:
PURPOSE: A hemostasis clip and hemostasis clip operating set are provided to effectively perform not only the function of clipping an exact bleeding area but also the simple function of clipping a hemostasis clip through the multiple structure of the first tong portion and the second tong portion. CONSTITUTION: A hemostasis clip operating set(20) comprises a handle portion(100), a first tong portion(210), a second tong portion(220), and a tong driving portion(300). A handle portion applies a direct external force to the tong driving portion to operate the hemostasis and the clipping of the first and the second tong potion while a surgical operator grips the hemostasis clip with hands. A clip bent portion has a predetermined elastic force to be pressurized and bent by the clip bent portion of the second tong.
Abstract:
PURPOSE: A surgical instrument is provided to improve a field of vision by sucking blood which is generated from a region where a surgical operation is performed. CONSTITUTION: A surgical instrument comprises a first main body part(110), a second main body part(120), a suction part(200), and a lighting part(300). At least one inlet part is formed in the leading end of the first main body part. The second main body part is crossed with the first main body part. The suction part is arranged in the first main body part in order to suck the blood which is generated from a surgical region through the inlet part. The suction part comprises a suction tube. The suction tube is inserted into the suction tube insertion hole of the first main body part. The suction tube is connected to the inlet part. The diameter of the inlet part is less than the diameter of the suction tube insertion hole. The lighting part is arranged in the second main body part in order to light between the first main body part and the second main body part.
Abstract:
본 발명은 m/z 3326.0, 6275.3, 9620.8 및 10094.0 중에서 선택된 하나 이상의 알고리즘을 조합하여 간세포암 (hepatocellular carcinoma) 과 상기 간세포암 이외의 선암을 감별하는 1 단계; m/z 3369.5, 5046.0, 6689.4, 10094.0, 10285.0, 및 13156.9 중에서 선택된 하나 이상의 알고리즘을 조합하여 유방암 (breast adenocarcinoma) 과 상기 유방암 이외의 암을 감별하는 2 단계; m/z 3369.5, 3440.7, 4225.0, 4935.7, 5824.7, 6575.8, 6665.8, 7936.4, 8041.1, 8452.9, 9749.8, 11652.9, 11986.6, 12171.6 및 12224.7 중에서 선택된 하나 이상의 알고리즘을 조합하여 폐선암 (lung adenocarcinoma) 과 상기 폐선암 이외의 암을 감별하는 3 단계; 및 m/z 3707.6, 4746.2, 4935.7, 5824.7, 7936.4, 8019.5 및 12344.3 중에서 선택된 하나 이상의 알고리즘을 조합하여, 위장관암을 대표하는 대장암(colorectal cancer)과 간내 담도암(intrahepatic cholangiocarcinoma)을 감별하는 4 단계로 이루어진 동결 암 조직에서의 MALDI 질량분석 패턴으로 원발부위 불명 선암의 조직 기원을 예측하는 방법에 관한 것이다.
Abstract:
PURPOSE: A hemostasis clip and hemostasis clip operating set are provided to effectively perform not only the function of clipping an exact bleeding area but also the simple function of clipping a hemostasis clip through the multiple structure of the first tong portion and the second tong portion. CONSTITUTION: A hemostasis clip operating set(20) comprises a handle portion(100), a first tong portion(210), a second tong portion(220), and a tong driving portion(300). A handle portion applies a direct external force to the tong driving portion to operate the hemostasis and the clipping of the first and the second tong potion while a surgical operator grips the hemostasis clip with hands. A clip bent portion has a predetermined elastic force to be pressurized and bent by the clip bent portion of the second tong.
Abstract:
PURPOSE: A surgical instrument is provided to improve a visual field by monitoring a surgical operation region through a handy camera. CONSTITUTION: A surgical instrument comprises a first body part(110), a second body part(120), a hinge part(200), and a photographing part. The second body part has a shape which is symmetrical to the first body part. The first body part and the second body part are rotatably combined with the hinge part. The hinge part comprises a hinge body and a hinge shaft. The hinge body is located between the first body part and the second body part. The hinge shaft is inserted into the hinge hole of the first body part and the second body part. The photographing part is arranged in the hinge part in order to photograph a surgical operation region between the leading end of the first body part and the leading end of the second body part.
Abstract:
PURPOSE: A method for predicting tissue origin of unknown primary adenocarcinoma is provided to distinguish hepatocellular carcinoma from lung cancer, breast cancer, and colon cancer. CONSTITUTION: A method for predicting tissue origin of unknown primary adenocarcinoma based on MALDI MS pattern comprises: a step of combining algorithm of m/z 3326.0, 6275.3, 9620.8 or 10094.0 and distinguishing hepatocellular carcinoma and adenocarcinoma except for hepatocellular carcinoma; a step of combining algorithm of m/z 3369.5, 5046.0, 6689.4, 10094.0, 10285.0, or13156.9 and distinguishing breast adenocarcinoma and other cancer except for breast adenocarcinoma; a step of combining algorithm of m/z 3369.5, 3440.7, 4225.0, 4935.7, 5824.7, 6575.8, 6665.8, 7936.4, 8041.1, 8452.9, 9749.8, 11652.9, 11986.6, 12171.6, or 12224.7 and distinguishing lung adenocarcinoma and other cancer except for lung adenocarcinoma; and a step of combining algorithm of m/z 3707.6, 4746.2, 4935.7, 5824.7, 7936.4, 8019.5 or 12344.3 and distinguishing colorectal cancer and intraheptic cholangiocarcinoma. [Reference numerals] (AA) Liver mass; (BB) MALDI MS for biopsy; (CC) Step 1: profiles for m/z 3326.0, 6275.3, 9620.8, 10094.0; (DD) Step 2: profiles for m/z 3369.5, 5046.0, 6689.4, 10094.0, 10285.0, 13156.9; (EE) Step 3: profiles for m/z 3369.5, 3440.7, 4225.0, 4935.7, 5824.7, 6575.8, 6665.8, 7936.4, 8041.1, 8452.9, 9749.8, 11652.9, 11986.6, 12171.6, 12224.7; (FF) Step 4: profiles for m/z 3707.6, 4746.2, 4935.7, 5824.7, 7936.4, 8019.5, 12344.3; (GG) Colon adenocarcinoma; (HH) Hepatocellular carcinoma; (II) Breast adenocarcinoma; (JJ) Lung adenocarcinoma; (KK) Intrahepatic cholangiocarcinoma
Abstract translation:目的:提供一种预测未知原发性腺癌组织起源的方法,以区分肝细胞癌与肺癌,乳腺癌和结肠癌。 构成:基于MALDI MS模式预测未知原发性腺癌的组织起源的方法包括:m / z 3326.0,6275.3,9620.8或10094.0的组合算法和肝细胞癌除外的区分肝细胞癌和腺癌的步骤; 结合m / z 3369.5,5046.0,6689.4,10094.0,10285.0或13156.9的算法和区分乳腺腺癌和乳腺腺癌以外的其他癌症的步骤; 组合m / z 3369.5,3440.7,4225.0,4935.7,5824.7,6575.8,6665.8,7936.4,8041.1,8452.9,9749.8,11652.9,11986.6,12171.6或12224.7的算法的步骤,区分肺腺癌和除肺腺癌之外的其它癌症 ; 以及组合m / z 3707.6,44746.2,4935.7,5824.7,7936.4,8019.5或12344.3的算法和区分结肠直肠癌和眼内胆管癌的步骤。 (AA)肝脏质量; (BB)用于活检的MALDI MS; (CC)步骤1:m / z 3326.0,6275.3,9620.8,10094.0的分布; (DD)步骤2:m / z 3363.5,5046.0,6689.4,10094.0,10285.0,13156.9的分布; (EE)步骤3:m / z 3369.5,3440.7,4225.0,4935.7,5824.7,6575.8,6665.8,7936.4,8041.1,8452.9,99749.8,11652.9,11986.6,12171.6,12224.7的分布; (FF)步骤4:m / z 370x.6,4746.2,4935.7,5824.7,7936.4,8019.5,12344.3的分布; (GG)结肠腺癌; (HH)肝细胞癌; (二)乳腺癌; (JJ)肺腺癌; (KK)肝内胆管癌